IDEX

IEX

Valor de mercado US$ 17,4 bi

Here is how Idex (IEX) and Murata Manufacturing Inc. (MRAAY) have performed compared to their sector so far this year.

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE:IEX) announced today that it will release its third quarter 2026 results on Wednesday, October 28, 2026, prior to market open. An investor conference call and webcast will take place at 8:00 a.m. (CT) that same day with Chief Executive Officer and President Eric Ashleman and Senior Vice President and Chief Financial Officer Sean Gillen. The webcast and related earnings presentation will be available in listen-only mode on the Company's I.

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.73 per common share. This dividend will be paid October 16, 2026 to shareholders of record as of October 2, 2026. This dividend represents the company's 128th consecutive regular quarterly cash dividend payment. About IDEX IDEX Corporation (NYSE: IEX), a global engineered products company, is comprised of three primary business segments.

IEX is gaining from strong HST demand, rising orders, acquisitions and shareholder returns as it lifts its 2026 organic sales growth outlook.

Here is how Idex (IEX) and Murata Manufacturing Inc. (MRAAY) have performed compared to their sector so far this year.

IEX is gaining from strong data center, semiconductor, space and defense demand, acquisitions and shareholder returns.

Idex (IEX) reported earnings 30 days ago. What's next for the stock?

Idex (IEX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Does Idex (IEX) have what it takes to be a top stock pick for momentum investors? Let's find out.

IDEX NYSE: IEX reported second-quarter 2026 results that exceeded its expectations, supported by growth in its Health & Science Technologies segment, stronger orders and operational execution. The company raised its full-year outlook for organic sales growth, adjusted EBITDA margin and adjusted earnings per share.